持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/07/16 | 7,130 | 7,180 | 7,130 | 7,150 | ±0 | ±0% | 8,700 |
2014/07/15 | 7,100 | 7,180 | 7,090 | 7,150 | +10 | +0.1% | 12,800 |
2014/07/14 | 7,080 | 7,170 | 7,060 | 7,140 | +90 | +1.3% | 14,100 |
2014/07/11 | 6,980 | 7,060 | 6,960 | 7,050 | -80 | -1.1% | 34,800 |
2014/07/10 | 7,230 | 7,230 | 7,120 | 7,130 | -110 | -1.5% | 16,500 |
2014/07/09 | 7,200 | 7,250 | 7,180 | 7,240 | +10 | +0.1% | 11,100 |
2014/07/08 | 7,210 | 7,250 | 7,180 | 7,230 | +10 | +0.1% | 18,500 |
2014/07/07 | 7,300 | 7,300 | 7,100 | 7,220 | -50 | -0.7% | 13,300 |
2014/07/04 | 7,290 | 7,300 | 7,260 | 7,270 | +10 | +0.1% | 11,300 |
2014/07/03 | 7,210 | 7,280 | 7,210 | 7,260 | -20 | -0.3% | 14,800 |
2014/07/02 | 7,200 | 7,310 | 7,200 | 7,280 | -10 | -0.1% | 26,000 |
2014/07/01 | 7,270 | 7,300 | 7,230 | 7,290 | +20 | +0.3% | 21,800 |
2014/06/30 | 7,130 | 7,270 | 7,070 | 7,270 | +140 | +2% | 28,700 |
2014/06/27 | 7,100 | 7,200 | 7,080 | 7,130 | ±0 | ±0% | 24,100 |
2014/06/26 | 7,170 | 7,200 | 7,130 | 7,130 | ±0 | ±0% | 18,500 |
2014/06/25 | 7,120 | 7,170 | 7,110 | 7,130 | +20 | +0.3% | 12,100 |
2014/06/24 | 7,070 | 7,190 | 7,000 | 7,110 | +70 | +1% | 25,100 |
2014/06/23 | 7,070 | 7,080 | 7,010 | 7,040 | -20 | -0.3% | 17,800 |
2014/06/20 | 6,960 | 7,070 | 6,930 | 7,060 | -10 | -0.1% | 46,000 |
2014/06/19 | 6,970 | 7,090 | 6,970 | 7,070 | +20 | +0.3% | 33,800 |
2014/06/18 | 7,060 | 7,080 | 7,040 | 7,050 | -10 | -0.1% | 16,500 |
2014/06/17 | 7,000 | 7,090 | 6,980 | 7,060 | +140 | +2% | 22,300 |
2014/06/16 | 6,990 | 7,000 | 6,900 | 6,920 | -70 | -1% | 16,200 |
2014/06/13 | 6,900 | 7,000 | 6,860 | 6,990 | +60 | +0.9% | 31,600 |
2014/06/12 | 6,880 | 6,970 | 6,850 | 6,930 | -40 | -0.6% | 18,200 |
2014/06/11 | 6,960 | 7,000 | 6,940 | 6,970 | +10 | +0.1% | 12,500 |
2014/06/10 | 6,990 | 7,030 | 6,940 | 6,960 | -20 | -0.3% | 22,900 |
2014/06/09 | 6,970 | 6,990 | 6,930 | 6,980 | +10 | +0.1% | 9,900 |
2014/06/06 | 7,040 | 7,040 | 6,940 | 6,970 | -30 | -0.4% | 19,900 |
2014/06/05 | 7,000 | 7,050 | 6,990 | 7,000 | +40 | +0.6% | 20,900 |
2014/06/04 | 6,940 | 6,980 | 6,890 | 6,960 | +20 | +0.3% | 25,000 |
2014/06/03 | 7,050 | 7,050 | 6,760 | 6,940 | -60 | -0.9% | 24,700 |
2014/06/02 | 6,960 | 7,040 | 6,930 | 7,000 | +140 | +2% | 17,400 |
2014/05/30 | 6,890 | 6,900 | 6,810 | 6,860 | -10 | -0.1% | 33,300 |
2014/05/29 | 6,890 | 6,900 | 6,810 | 6,870 | -30 | -0.4% | 14,400 |
2014/05/28 | 6,920 | 6,930 | 6,840 | 6,900 | -20 | -0.3% | 42,500 |
2014/05/27 | 6,980 | 7,000 | 6,920 | 6,920 | -30 | -0.4% | 14,900 |
2014/05/26 | 7,000 | 7,000 | 6,900 | 6,950 | +50 | +0.7% | 20,700 |
2014/05/23 | 6,890 | 6,940 | 6,870 | 6,900 | +70 | +1% | 17,700 |
2014/05/22 | 6,820 | 6,860 | 6,740 | 6,830 | +100 | +1.5% | 17,900 |
2014/05/21 | 6,770 | 6,770 | 6,680 | 6,730 | -70 | -1% | 28,700 |
2014/05/20 | 6,860 | 6,870 | 6,790 | 6,800 | -50 | -0.7% | 20,200 |
2014/05/19 | 6,760 | 6,940 | 6,760 | 6,850 | +30 | +0.4% | 31,900 |
2014/05/16 | 6,840 | 6,840 | 6,750 | 6,820 | -160 | -2.3% | 29,900 |
2014/05/15 | 7,030 | 7,030 | 6,910 | 6,980 | -80 | -1.1% | 27,500 |
2014/05/14 | 7,030 | 7,060 | 6,960 | 7,060 | -10 | -0.1% | 20,700 |
2014/05/13 | 7,120 | 7,130 | 7,020 | 7,070 | +20 | +0.3% | 17,800 |
2014/05/12 | 7,050 | 7,200 | 7,000 | 7,050 | -120 | -1.7% | 29,100 |
2014/05/09 | 7,080 | 7,190 | 7,020 | 7,170 | +60 | +0.8% | 20,900 |
2014/05/08 | 7,060 | 7,150 | 6,980 | 7,110 | +20 | +0.3% | 30,800 |
2651~
2700
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム